⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1635363 | 1.00 | — | — | |
| SCHEMBL26751260 | 1.00 | MEN1 (0.69) | — | |
| SCHEMBL11602747 | 0.97 | KDM4E (0.75) | — | |
| Water SCHEMBL29126248 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL58640 | 0.97 | — | — | |
| Piperazine SCHEMBL3367356 | 0.97 | KDM4E (0.75) | — | |
| SCHEMBL12009416 | 0.97 | MEN1 (0.75) | — | |
| SCHEMBL26751258 | 0.94 | KDM4E (0.71) | — | |
| SCHEMBL19180206 | 0.93 | — | — | |
| SCHEMBL624587 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 12587 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630548-B2 | Azetidine derivatives for the treatment of integrin associated diseases | THE UNIVERSITY OF NOTTINGHAM (GB) | 2026-05-19 | — | — | US | claimed |
| EP-4041730-B1 | SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS | BRISTOL MYERS SQUIBB CO (US) | 2026-05-13 | — | — | EP | claimed |
| EP-4731223-A1 | MORPHOLINE AND 1,4-OXAZEPANE COMPOUNDS AND ITS USE IN THERAPY | Universitat De Barcelona (ES) | 2026-04-29 | — | — | EP | claimed |
| US-20260070896-A1 | HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | UNIV LEUVEN KATH (BE) | 2026-03-12 | — | — | US | claimed |
| US-12539305-B2 | Methods of treating cancer with an mTOR inhibitor | Revolution Medicines, Inc. (US) | 2026-02-03 | — | — | US | claimed |
| US-20260014124-A1 | USE OF MTOR INHIBITORS FOR PREVENTION OF INTESTINAL POLYP GROWTH AND CANCER | UNIV TEXAS (US) | 2026-01-15 | — | — | US | claimed |
| US-20250388543-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-12-25 | — | — | US | claimed |
| US-12496296-B2 | Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases | ALKAHEST, INC. (US) | 2025-12-16 | — | — | US | claimed |
| US-20250376468-A1 | PYRAZOLO[1,5-a]PYRIDINE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS | UNIV LEUVEN KATH (BE) | 2025-12-11 | — | — | US | claimed |
| US-20250376469-A1 | INDOLIZINE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS | UNIV LEUVEN KATH (BE) | 2025-12-11 | — | — | US | claimed |
| US-4680358-A | Styryl terminated macromolecular monomers of polyethers | THE B F GOODRICH COMPANY (US) | 1987-07-14 | — | — | US | claimed |
| EP-0221551-A2 | Styryl terminated macromolecular monomers of polyethers | The B.F. GOODRICH Company (US) | 1987-05-13 | — | — | EP | claimed |
| EP-0218079-A2 | Allyl terminated macromolecular monomers of polyethers | The B.F. GOODRICH Company (US) | 1987-04-15 | — | — | EP | claimed |
| EP-0013749-B1 | HEXAHYDRO-1,4-OXAZEPINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1982-05-12 | — | — | EP | claimed |
| EP-0045631-A2 | Synthesis of dioxabicyclo(3.2.1)octanes and oxepanes | ORTHO PHARMACEUTICAL CORPORATION (US) | 1982-02-10 | — | — | EP | claimed |
| EP-0038696-A2 | Synthesis of dioxabicyclo(3.2.1.)octanes and oxepanes | ORTHO PHARMACEUTICAL CORPORATION (US) | 1981-10-28 | — | — | EP | claimed |
| US-4276216-A | Synthesis of dioxabicyclo[3.2.1]octanes and oxepanes | ORTHO PHARMACEUTICAL CORPORATION (US) | 1981-06-30 | — | — | US | claimed |
| US-4269833-A | 7-/3-HYDROXY-, OXY-, OR CARBONYLOXY-SUBSTITUTED/PHENYL DERIVATIVES; ANALGESICS | BASF AKTIENGESELLSCHAFT (DE) | 1981-05-26 | — | — | US | claimed |
| EP-0013749-A1 | Hexahydro-1,4-oxazepines, process for their preparation and pharmaceutical compositions containing them | BASF Aktiengesellschaft (DE) | 1980-08-06 | — | — | EP | claimed |
| US-4182717-A | Total synthesis of the utero-evacuant substance d,l-zoapatanol | ORTHO PHARMACEUTICAL CORP. (US) | 1980-01-08 | — | — | US | claimed |